V. Rao et al., Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery, ANN THORAC, 71(6), 2001, pp. 1925-1930
Citations number
20
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Background. Cardioplegic arrest induces anaerobic myocardial metabolism wit
h a net production of lactate from glycolysis. However, persistent lactate
release during reperfusion suggests a delayed recovery oi normal aerobic me
tabolism and may lead to depressed myocardial function necessitating inotro
pic or intraaortic balloon pump support (low output syndrome [LOS]). We exa
mined the relation between perioperative myocardial metabolism and postoper
ative clinical outcomes in patients undergoing isolated coronary artery byp
ass surgery (CABG).
Methods. We reviewed 623 patients who were enrolled in clinical studies eva
luating perioperative myocardial metabolism between 1983 and 1996. Arterial
and coronary sinus blood samples were obtained intraoperatively to assess
myocardial metabolism. Clinical data regarding patient demographics and pos
toperative outcomes were prospectively collected and entered into our insti
tutional database.
Results. Low output syndrome developed in 36 patients (5.8%). Myocardial la
ctate release was higher in these patients compared with those who did not
develop postoperative LOS, Advanced age and poor preoperative left ventricu
lar function were independent predictors of lactate release during reperfus
ion. Persistent lactate release after 5 minutes of reperfusion was the only
independent predictor of postoperative LOS in this low-risk population.
Conclusions. Persistent lactate release during reperfusion occurs in a sign
ificant proportion of low-risk patients undergoing isolated CABG and is an
independent predictor of postoperative low cardiac output syndrome. Persist
ent lactate release during reperfusion suggests a delayed recovery of aerob
ic myocardial metabolism and may be related to intraoperative misadventure
or inadequate myocardial protection. Myocardial lactate release may be usef
ul as an alternative end-point in clinical trials evaluating perioperative
myocardial protection. (C) 2001 by The Society of Thoracic Surgeons.